TB Alliance

TB Alliance Welcomes New Board Members

September 30, 2021

NEW YORK (Sept 30, 2021)—TB Alliance, a not-for-profit organization dedicated to development and delivery of improved regimens to fight tuberculosis

September 29, 2021

Dr. Eric Goosby, Sundar Kodiyalam, David Y. Norton, and Sangita Reddy Join Board NEW YORK (Sept 29, 2021)—TB Alliance, a

September 6, 2021

Agreement between non-profit product development partnership and multinational pharmaceutical company will expand access to new TB drug NEW YORK and

August 19, 2021

TB Alliance’s Community Engagement (CE) forums provide an opportunity for capacity building and for members of TB-affected communities to share

August 2, 2021

TB Alliance has built the largest portfolio of potential new tuberculosis (TB) treatments in history. Since inception, it has introduced

July 30, 2021

When TB Alliance was formed, there had been no late-stage tuberculosis (TB) research trials conducted to modern standards. In addition

July 28, 2021

Unfortunately, the recent history of the tuberculosis (TB) pandemic has in large part been defined by neglect—inadequate funding for research

July 15, 2021

NEW YORK (July 15, 2021)—To advance anti-tuberculosis (TB) science and enable the progression of new, safe, and affordable treatment solutions

July 15, 2021

TB Alliance’s ZeNix trial in South Africa and Eastern Europe sought to optimize the 6-month treatment regimen with reduced exposure

July 13, 2021

He will bring more than 20 years of global and country level experience in TB and a people-centered approach to